Zachary M Holliday1,2, Janice L Launspach1, Lakshmi Durairaj1, Pradeep K Singh3, Joseph Zabner4, David A Stoltz5. 1. Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA, USA. 2. Department of Medicine, University of Missouri School of Medicine, Columbia, MO, USA. 3. Departments of Microbiology and Medicine, University of Washington, Seattle, WA, USA. 4. Department of Internal Medicine and Pappajohn Biomedical Institute, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA, USA. 5. Departments of Biomedical Engineering, Molecular Physiology, and Biophysics, Internal Medicine and Pappajohn Biomedical Institute, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
Abstract
OBJECTIVES: In cystic fibrosis (CF), loss of CFTR-mediated bicarbonate secretion reduces the airway surface liquid (ASL) pH causing airway host defense defects. Aerosolized sodium bicarbonate can reverse these defects, but its effects are short-lived. Aerosolized tromethamine (THAM) also raises the ASL pH but its effects are much longer lasting. In this pilot study, we tested the hypothesis that nasally administered THAM would alter the nasal bacterial composition in adults with and without CF. METHODS: Subjects (n = 32 total) received intranasally administered normal saline or THAM followed by a wash out period prior to receiving the other treatment. Nasal bacterial cultures were obtained prior to and after each treatment period. RESULTS: At baseline, nasal swab bacterial counts were similar between non-CF and CF subjects, but CF subjects had reduced microbial diversity. Both nasal saline and THAM were well-tolerated. In non-CF subjects, nasal airway alkalinization decreased both the total bacterial density and the gram-positive bacterial species recovered. In both non-CF and CF subjects, THAM decreased the amount of Corynebacterium accolens detected, but increased the amount of Corynebacterium pseudodiphtheriticum recovered on nasal swabs. A reduction in Staphylococcus aureus nasal colonization was also found in subjects who grew C. pseudodiphtheriticum. CONCLUSIONS: This study shows that aerosolized THAM is safe and well-tolerated and that nasal airway alkalinization alters the composition of mucosal bacterial communities. CLINICAL TRIAL REGISTRATION: NCT00928135 (https://clinicaltrials.gov/ct2/show/NCT00928135).
OBJECTIVES: In cystic fibrosis (CF), loss of CFTR-mediated bicarbonate secretion reduces the airway surface liquid (ASL) pH causing airway host defense defects. Aerosolized sodium bicarbonate can reverse these defects, but its effects are short-lived. Aerosolized tromethamine (THAM) also raises the ASL pH but its effects are much longer lasting. In this pilot study, we tested the hypothesis that nasally administered THAM would alter the nasal bacterial composition in adults with and without CF. METHODS: Subjects (n = 32 total) received intranasally administered normal saline or THAM followed by a wash out period prior to receiving the other treatment. Nasal bacterial cultures were obtained prior to and after each treatment period. RESULTS: At baseline, nasal swab bacterial counts were similar between non-CF and CF subjects, but CF subjects had reduced microbial diversity. Both nasal saline and THAM were well-tolerated. In non-CF subjects, nasal airway alkalinization decreased both the total bacterial density and the gram-positive bacterial species recovered. In both non-CF and CF subjects, THAM decreased the amount of Corynebacterium accolens detected, but increased the amount of Corynebacterium pseudodiphtheriticum recovered on nasal swabs. A reduction in Staphylococcus aureus nasal colonization was also found in subjects who grew C. pseudodiphtheriticum. CONCLUSIONS: This study shows that aerosolized THAM is safe and well-tolerated and that nasal airway alkalinization alters the composition of mucosal bacterial communities. CLINICAL TRIAL REGISTRATION: NCT00928135 (https://clinicaltrials.gov/ct2/show/NCT00928135).
Authors: J Zabner; M P Seiler; J L Launspach; P H Karp; W R Kearney; D C Look; J J Smith; M J Welsh Journal: Proc Natl Acad Sci U S A Date: 2000-10-10 Impact factor: 11.205
Authors: Miling Yan; Sünje J Pamp; Julia Fukuyama; Peter H Hwang; Do-Yeon Cho; Susan Holmes; David A Relman Journal: Cell Host Microbe Date: 2013-12-11 Impact factor: 21.023
Authors: N V Kiryukhina; V G Melnikov; A V Suvorov; Yu A Morozova; V K Ilyin Journal: Probiotics Antimicrob Proteins Date: 2013-12 Impact factor: 4.609
Authors: David A Stoltz; Tatiana Rokhlina; Sarah E Ernst; Alejandro A Pezzulo; Lynda S Ostedgaard; Philip H Karp; Melissa S Samuel; Leah R Reznikov; Michael V Rector; Nicholas D Gansemer; Drake C Bouzek; Mahmoud H Abou Alaiwa; Mark J Hoegger; Paula S Ludwig; Peter J Taft; Tanner J Wallen; Christine Wohlford-Lenane; James D McMenimen; Jeng-Haur Chen; Katrina L Bogan; Ryan J Adam; Emma E Hornick; George A Nelson; Eric A Hoffman; Eugene H Chang; Joseph Zabner; Paul B McCray; Randall S Prather; David K Meyerholz; Michael J Welsh Journal: J Clin Invest Date: 2013-05-08 Impact factor: 14.808
Authors: Lynda S Ostedgaard; David K Meyerholz; Jeng-Haur Chen; Alejandro A Pezzulo; Philip H Karp; Tatiana Rokhlina; Sarah E Ernst; Robert A Hanfland; Leah R Reznikov; Paula S Ludwig; Mark P Rogan; Greg J Davis; Cassie L Dohrn; Christine Wohlford-Lenane; Peter J Taft; Michael V Rector; Emma Hornick; Boulos S Nassar; Melissa Samuel; Yuping Zhang; Sandra S Richter; Aliye Uc; Joel Shilyansky; Randall S Prather; Paul B McCray; Joseph Zabner; Michael J Welsh; David A Stoltz Journal: Sci Transl Med Date: 2011-03-16 Impact factor: 17.956
Authors: André Schultz; Ramaa Puvvadi; Sergey M Borisov; Nicole C Shaw; Ingo Klimant; Luke J Berry; Samuel T Montgomery; Thien Nguyen; Silvia M Kreda; Anthony Kicic; Peter B Noble; Brian Button; Stephen M Stick Journal: Nat Commun Date: 2017-11-10 Impact factor: 14.919
Authors: Mark J Hoegger; Anthony J Fischer; James D McMenimen; Lynda S Ostedgaard; Alex J Tucker; Maged A Awadalla; Thomas O Moninger; Andrew S Michalski; Eric A Hoffman; Joseph Zabner; David A Stoltz; Michael J Welsh Journal: Science Date: 2014-08-15 Impact factor: 47.728
Authors: Jamison J Ash; Brieanna M Hilkin; Nicholas D Gansemer; Eric A Hoffman; Joseph Zabner; David A Stoltz; Mahmoud H Abou Alaiwa Journal: Physiol Rep Date: 2022-09